Target intelligence / Profile preview

Ependymin-related protein 1 (EPDR1)

Target
EPDR1
Molecular classification
Other (LolA/EPDR fold protein, not an enzyme, receptor, transporter, or typical signaling protein), Lysosomal glycoprotein
01

Overview

Ependymin-related protein 1 (EPDR1) is a conserved, glycosylated lysosomal protein found in vertebrates, including humans. Structurally, EPDR1 adopts a dimeric LolA/EPDR fold with deep hydrophobic grooves, suggesting a function in lipid binding or transport, particularly in the context of lysosomal lipid metabolism or as a lipid activator protein[1][3]. It exhibits sequence and structural homology to bacterial lipoprotein transporters (LolA/LolB), but its precise physiological substrates remain unidentified[1][3]. EPDR1 is implicated in modulating lysosomal glycosphingolipid-processing enzymes and has a role in cellular metabolism, including positive regulation of glucose-stimulated insulin secretion in pancreatic β-cells[7]. In disease, EPDR1 expression and genetic variants are associated with colorectal cancer, metabolic dysfunction, and glaucoma, but no direct small molecule inhibitors or drugs targeting EPDR1 are known at present[5]. The protein is not currently classified as a classical therapeutic target such as a receptor or enzyme.

Other names
Mammalian ependymin-related protein 1MERP1UCC1EPDRUpregulated in colorectal cancer gene 1 proteinependymin related protein 1
02

Biological functions

Lipid bindingLipid transport (putative)Lysosomal activator (putative)Modulation of lysosomal enzyme activity (e.g., regulating glycosphingolipids processing)Potential roles in calcium-dependent cell adhesionRegulation of cellular metabolism (e.g., β-cell metabolism, insulin secretion in the pancreas)
03

Disease associations

Cancer (e.g., upregulation observed in colorectal cancer)Metabolic disease (e.g., implicated in β-cell function, diabetes)Ocular disease (associated with primary angle-closure glaucoma and related forms)Other (potential neurologic/neuronal lipid disorders)
04

Biomarkers

EPDR1 expression level (prognostic in some cancers, e.g., colorectal cancer)Genetic variants (SNPs associated with glaucoma risk)

Beyond the preview

Go deeper on Ependymin-related protein 1 (EPDR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ependymin-related protein 1 (EPDR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call